Moleculin Biotech Debt to Equity Ratio Analysis

Moleculin Biotech Inc (MBRX)

2.90 +0.07 (+2.47%) USD | NASDAQ | Nov 22, 15:30

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to . Upgrade now.

Date	Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

Agilent Technologies Inc	0.4967
Seelos Therapeutics Inc	--
Cara Therapeutics Inc	0.00
Citius Pharmaceuticals Inc	--
NovaBay Pharmaceuticals Inc	0.0476

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	23.39M
Total Liabilities (Quarterly)	15.92M
Shareholders Equity (Quarterly)	7.479M